Alpha 2.0
Login Register
» Articles » PMID: 8267734

Comment on the Nottingham Prognostic Index

Overview
Journal Breast Cancer Res Treat
Specialty Oncology
Date 1993 Jan 1
PMID 8267734
Citations 9
Authors
J Brown
M Jones
E A Benson
Affiliations
Soon will be listed here.
Citing Articles

Advancement of prognostic models in breast cancer: a narrative review.

Min N, Wei Y, Zheng Y, Li X Gland Surg. 2021; 10(9):2815-2831.

PMID: 34733730 PMC: 8514300. DOI: 10.21037/gs-21-441.

Prognostic models for breast cancer: a systematic review.

Phung M, Tin Tin S, Elwood J BMC Cancer. 2019; 19(1):230.

PMID: 30871490 PMC: 6419427. DOI: 10.1186/s12885-019-5442-6.

Comparison of Oncotype DX® Recurrence Score® with other risk assessment tools including the Nottingham Prognostic Index in the identification of patients with low-risk invasive breast cancer.

Cotter M, Dakin A, Maguire A, Walshe J, Kennedy M, Dunne B Virchows Arch. 2017; 471(3):321-328.

PMID: 28707056 DOI: 10.1007/s00428-017-2184-1.

Determination of GP88 (progranulin) expression in breast tumor biopsies improves the risk predictive value of the Nottingham Prognostic Index.

Serrero G, Hawkins D, Bejarano P, Ioffe O, Tkaczuk K, Elliott R Diagn Pathol. 2016; 11(1):71.

PMID: 27501955 PMC: 4977669. DOI: 10.1186/s13000-016-0520-4.

Nottingham Prognostic Index Plus: Validation of a clinical decision making tool in breast cancer in an independent series.

Green A, Soria D, Stephen J, Powe D, Nolan C, Kunkler I J Pathol Clin Res. 2016; 2(1):32-40.

PMID: 27499914 PMC: 4858129. DOI: 10.1002/cjp2.32.